Gene therapy could treat inherited blindness

Article

DNA elements have been identified that control when and where genes linked to blindness are "switched on".

DNA elements have been identified that control when and where genes linked to blindness are "switched on", according to researchers at Washington University School of Medicine, St Louis, USA.

Using a computational analysis of DNA to search for elements that can turn on genes in the photoreceptor cells of the eye, the investigators have identified hundreds of potential cis-regulatory elements (DNA segments involved in activating and deactiviating genes). Nineteen of these elements have now been confirmed, more than doubling the number previously identified.

The results of this study will be used to design gene therapy vectors for a form of Leber's congenital amaurosis, an inherited disorder that leaves patients blind from birth.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.